Prostate Pathology Reporting Survey
Prostate cancer is the most common cancer in men and the demand for detailed prostate pathology diagnostics is significant. Men suspected of having prostate cancer usually have a biopsy to confirm the presence of cancer and the biopsy is examined and reported on by a Pathologist. Men with prostate cancer who opt to have their prostate removed surgically will also have the prostate examined and reported on by a Pathologist.
In the UK prostate tissue is examined and reported by Pathologists following guidelines set out by the Royal College of Pathologists (RCPath), which suggest that reports include a number of diagnostic and prognostic features, such as tumour grade (Gleason grade), tumour size, extent of invasion etc. While these suggestions are based on clinical studies, it is not always clear how useful the details are for surgical and oncology teams. This study aims to establish what the clinical teams think about prostate pathology reports and hopes to stream-line and improve pathology reports, to increase the efficiency of pathology services, and improve patient care. The study will conduct a survey of UK clinicians (surgeons and oncologists) to ask about their views on pathology reports, and is expected to begin in Spring 2021.
The project is currently being reviewed by the Oxford University Medical Sciences Division ethics committee (CUREC / MS IDREC Committee, application number R74574/RE001). More information will be posted here in due course.